Lifecore Biomedical Inc. logo

Lifecore Biomedical Inc.

LFCR | NASDAQ
Chart Builder DCF Calculator
$4.47
-$0.01 (-0.22%)
Sep 22, 2026, 11:48 AM ET · Market open

Market Data

Market Cap
$168.04M
Enterprise Value
$305.87M
Beta
1.09
Average Volume
180.11K
Shares Outstanding (Diluted)
37.57M
Shares Change YoY
1.48%
Institutional Ownership
67.01%
Exchange
NASDAQ
ISIN
US5147661046

Price Performance

Price Change 1M
-1.5%
Price Change 3M
-20.9%
Price Change 6M
6.9%
Price Change YTD
-42.1%
Price Change 1Y
-43.1%
Price Change 3Y
-44.3%
Price Change 5Y
-56.2%
1M CAGR (ann.)
-10.6%
1Y CAGR (ann.)
-43.5%
5Y CAGR (ann.)
-15.6%
All-Time CAGR
-3.7%

Valuation

PE Ratio
-4.07
Forward PE
N/A
PEG Ratio
0.33
Forward PEG
0.32
PS Ratio
1.37
Forward PS
1.30
PB Ratio
10.44
P/FCF Ratio
-93.51
P/Adj. FCF Ratio
-16.71
P/OCF Ratio
74.67
EV/Sales
2.49
EV/EBIT
-22.72
EV/EBITDA
-73.90
EV/FCF
-170.21
Earnings Yield
-24.6%
FCF Yield
-1.1%
Adj. FCF Yield
-6.0%

Financial Health

Net Debt
$137.83M
Total Debt
$155.07M
Cash & Short-Term Investments
$17.24M
Total Assets
$229.5M
Current Ratio
3.87
Quick Ratio
2.69
Debt / Equity Ratio
9.64
Debt / EBITDA
-37.47
Debt / FCF
-86.29
OCF / Debt
0.01
Interest Coverage
-0.09
Altman Z-Score
-0.35
Piotroski F-Score
3

Margins & Profitability

Gross Profit Margin
29.7%
Operating Profit Margin
-2.1%
EBITDA Margin
-3.4%
Net Profit Margin
-30.4%
FCF Margin
-1.5%
Adj. FCF Margin
-8.2%
SBC / Revenue
6.7%
SBC Impact (per share)
-459.6%

Returns

Return on Assets
-16.3%
Return on Equity
-376.9%
Return on Invested Capital
-1.3%
Return on Capital Employed
-1.3%
Return on Tangible Assets
-17.3%

Historical Growth (CAGR)

Revenue CAGR 3Y
7.9%
Revenue CAGR 5Y
-22.9%
Revenue CAGR 10Y
-13.8%
EPS CAGR 3Y
-92.6%
EPS CAGR 5Y
36.3%
EPS CAGR 10Y
-22.0%
FCF CAGR 3Y
73.0%
FCF CAGR 5Y
49.8%
FCF CAGR 10Y
-1.7%

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
7
EPS Growth Next 3Y
17.6%
Revenue Growth Next 3Y
14.5%
Earnings Date
Nov 2, 2026
EPS Estimate (next Q)
-$0.30
EPS Growth Est (next Q)
2.6%
Revenue Est (next Q)
$25.57M
Revenue Growth Est (next Q)
-17.8%

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$6.50
Price Target Upside
45.1%

Cash Flow

Operating Cash Flow
$2.08M
Free Cash Flow
$-1.8M
Adj. Free Cash Flow
$-10.06M
FCF Per Share
-$0.05
OCF Per Share
$0.06
OCF/S Ratio
1.7%

Income Statement

Revenue
$122.64M
Gross Profit
$36.4M
Operating Income
$-2.61M
EBITDA
$-4.14M
Net Income
$-37.28M
EPS (Diluted)
-$1.10
Revenue / Employee
$321.04K
Profit / Employee
$-97.6K
Employees
382

© 2026 bestshares.com. All rights reserved.